Plus therapeutics successfully completes key milestone for cgmp manufacture of lead investigational radiotherapeutic

Completes technology transfer and initiates cgmp manufacturing for critical rhenium-186 nanoliposome ( 186 rnl) drug product intermediate

PSTV Ratings Summary

PSTV Quant Ranking